Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Secondary Prevention of Cardiovascular Events in Pre-Diabetes with CAD
NCT01574820Phase 3Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Nov 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rosiglitazone in coronary artery disease (CAD), prediabetes, sponsored by National Cheng Kung University Hospital. Started Nov 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
coronary artery disease (CAD)prediabetes
Beyond the preview
Go deeper on NCT01574820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574820.